| Name | Title | Contact Details |
|---|---|---|
Nell Beattie |
Chief Financial Officer and Head of Corporate | Profile |
John Dillman |
Chief Commercial Officer | Profile |
BioMotiv is an accelerator company associated with The Harrington Project, a $340 million initiative centered at University Hospitals of Cleveland.
gloStream is a Troy, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Merrimack is a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer. Merrimack seeks to gain a deeper understanding of underlying cancer biology through its systems biology-based approach and develop new insights, therapeutics and diagnostics to improve outcomes for cancer patients. Merrimack has multiple oncology therapeutics in clinical development and additional candidates in late stage preclinical development. Merrimack has a New Drug Application under review for its lead product candidate, MM-398, for the treatment of patients with metastatic adenocarcinoma of the pancreas who have been previously treated with gemcitabine-based therapy.
Phenomenex is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
Apic Bio is committed to finding cures for patients with genetic diseases.